Finer Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Finer Wealth Management's PFE Position: Q2 2026 in Review
Finer Wealth Management increased its Pfizer (PFE) stake by 5.8% in Q2 2026, buying an estimated $17.1K and bringing the position to 11,896 shares worth $286K. The position accounts for 0.13% of the portfolio, ranked #77.
Finer Wealth Management first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.24M in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Finer Wealth Management held 11,896 shares of Pfizer worth $286K as of Q2 2026.
- Finer Wealth Management bought 653 Pfizer shares in Q2 2026, an estimated $17.1K.
- Pfizer made up 0.13% of Finer Wealth Management's portfolio in Q2 2026, its #77 holding.
- Finer Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Finer Wealth Management's Pfizer position peaked at $4.24M in Q4 2021.
- 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Finer Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.